|
1
|
Killock D: CNS cancer: Molecular
classification of glioma. Nat Rev Clin Oncol. 12:5022015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walker MD, Alexander E Jr, Hunt WE,
MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Owens G,
Ransohoff J, Wilson CB, et al: Evaluation of BCNU and/or
radiotherapy in the treatment of anaplastic gliomas. A cooperative
clinical trial. J Neurosurg. 49:333–343. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Debus J and Abdollahi A: For the next
trick: New discoveries in radiobiology applied to glioblastoma. Am
Soc Clin Oncol Educ Book. e95–e99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan QW and Weiss WA: Targeting the
RTK-PI3K-mTOR axis in malignant glioma: Overcoming resistance. Curr
Top Microbiol Immunol. 347:279–296. 2010.PubMed/NCBI
|
|
5
|
El-Deiry WS: The role of p53 in
chemosensitivity and radiosensitivity. Oncogene. 22:7486–7495.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
King HO, Brend T, Payne HL, Wright A, Ward
TA, Patel K, Egnuni T, Stead LF, Patel A, Wurdak H, et al: RAD51 is
a selective DNA repair target to radiosensitize glioma stem cells.
Stem Cell Reports. 8:125–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Gent DC, Hoeijmakers JH and Kanaar R:
Chromosomal stability and the DNA double-stranded break connection.
Nat Rev Genet. 2:196–206. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dobbs TA, Tainer JA and Lees-Miller SP: A
structural model for regulation of NHEJ by DNA-PKcs
autophosphorylation. DNA Repair. 9:1307–1314. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Perrault AR, Takeda Y, Qin W, Wang
H and Iliakis G: Biochemical evidence for Ku-independent backup
pathways of NHEJ. Nucleic Acids Res. 31:5377–5388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dimitrova N, Chen YC, Spector DL and de
Lange T: 53BP1 promotes non-homologous end joining of telomeres by
increasing chromatin mobility. Nature. 456:524–528. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
DiTullio RA Jr, Mochan TA, Venere M,
Bartkova J, Sehested M, Bartek J and Halazonetis TD: 53BP1
functions in an ATM-dependent checkpoint pathway that is
constitutively activated in human cancer. Nat Cell Biol.
4:998–1002. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lieber MR, Ma Y, Pannicke U and Schwarz K:
Mechanism and regulation of human non-homologous DNA end-joining.
Nat Rev Mol Cell Biol. 4:712–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sánchez GM, Re L, Giuliani A, Núñez-Sellés
AJ, Davison GP and León-Fernández OS: Protective effects of
Mangifera indica L. extract, mangiferin and selected antioxidants
against TPA-induced biomolecules oxidation and peritoneal
macrophage activation in mice. Pharmacol Res. 42:565–573. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guha S, Ghosal S and Chattopadhyay U:
Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a
naturally occurring glucosylxanthone. Chemotherapy. 42:443–451.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duang XY, Wang Q, Zhou XD and Huang DM:
Mangiferin: A possible strategy for periodontal disease to therapy.
Med Hypotheses. 76:486–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HL, Li CY, Zhang B, Liu YD, Lu BM,
Shi Z, An N, Zhao LK, Zhang JJ, Bao JK, et al: Mangiferin
facilitates islet regeneration and β-cell proliferation through
upregulation of cell cycle and β-cell regeneration regulators. Int
J Mol Sci. 15:9016–9035. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, He X, Lei T, Liu Y, Huai G, Sun M,
Deng S, Yang H, Tong R and Wang Y: Mangiferin induces islet
regeneration in aged mice through regulating p16INK4a.
Int J Mol Med. 41:3231–3242. 2018.PubMed/NCBI
|
|
19
|
Garcia-Rivera D, Delgado R, Bougarne N,
Haegeman G and Berghe WV: Gallic acid indanone and mangiferin
xanthone are strong determinants of immunosuppressive anti-tumour
effects of Mangifera indica L. bark in MDA-MB231 breast cancer
cells. Cancer Lett. 305:21–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Noratto GD, Bertoldi MC, Krenek K, Talcott
ST, Stringheta PC and Mertens-Talcott SU: Anticarcinogenic effects
of polyphenolics from mango (Mangifera indica) varieties. J Agric
Food Chem. 58:4104–4112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi W, Deng J, Tong R, Yang Y, He X, Lv J,
Wang H, Deng S, Qi P, Zhang D, et al: Molecular mechanisms
underlying mangiferin-induced apoptosis and cell cycle arrest in
A549 human lung carcinoma cells. Mol Med Rep. 13:3423–3432. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chieli E, Romiti N, Rodeiro I and Garrido
G: In vitro effects of Mangifera indica and polyphenols derived on
ABCB1/P-glycoprotein activity. Food Chem Toxicol. 47:2703–2710.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng P, Peng ZG, Yang J and Song SJ: The
effect of mangiferin on telomerase activity and apoptosis in
leukemic K562 cells. Zhong Yao Cai. 30:306–309. 2007.(In Chinese).
PubMed/NCBI
|
|
24
|
Peng ZG, Luo J, Xia LH, Chen Y and Song
SJ: CML cell line K562 cell apoptosis induced by mangiferin.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 12:590–594. 2004.(In Chinese).
PubMed/NCBI
|
|
25
|
Percival SS, Talcott ST, Chin ST, Mallak
AC, Lounds-Singleton A and Pettit-Moore J: Neoplastic
transformation of BALB/3T3 cells and cell cycle of HL-60 cells are
inhibited by mango (Mangifera indica L.) juice and mango juice
extracts. J Nutri. 136:1300–1304. 2006. View Article : Google Scholar
|
|
26
|
Chari NS, Pinaire NL, Thorpe L, Medeiros
LJ, Routbort MJ and McDonnell TJ: The p53 tumor suppressor network
in cancer and the therapeutic modulation of cell death. Apoptosis.
14:336–347. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou B, Wang H, Liu Y, Qi P, Lei T, Sun M
and Wang Y: Mangiferin induces apoptosis in human ovarian
adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol
Rep. 38:1431–1441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao J, Liu L, Zhong Z, Xiao C and Zhang
J: Mangiferin regulates proliferation and apoptosis in glioma cells
by induction of microRNA-15b and inhibition of MMP-9 expression.
Oncol Rep. 33:2815–2820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung JS, Jung K, Kim DH and Kim HS:
Selective inhibition of MMP-9 gene expression by mangiferin in
PMA-stimulated human astroglioma cells: Involvement of PI3K/Akt and
MAPK signaling pathways. Pharmacol Res. 66:95–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andreu Pardo GL, Maurmann N, Reolon GK, de
Farias CB, Schwartsmann G, Delgado R and Roesler R: Mangiferin, a
naturally occurring glucoxilxanthone improves long-term object
recognition memory in rats. Eur J Pharmacol. 635:124–128. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Boyé K, Pujol N, Alves D I, Chen YP,
Daubon T, Lee YZ, Dedieu S, Constantin M, Bello L, Rossi M, et al:
The role of CXCR3/LRP1 cross-talk in the invasion of primary brain
tumors. Nat Commun. 8:15712017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Volpin F, Casaos J, Sesen J, Mangraviti A,
Choi J, Gorelick N, Frikeche J, Lott T, Felder R, Scotland SJ, et
al: Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma
therapeutic. Oncogene. 36:3037–3047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y, Lei T, Du S, Tong R, Wang H, Yang
J, Huang J, Sun M, Wang Y and Dong Z: Nuclear GSK3β induces DNA
double-strand break repair by phosphorylating 53BP1 in
glioblastoma. Int J Oncol. 52:709–720. 2018.PubMed/NCBI
|
|
36
|
Valavanidis A, Vlachogianni T and Fiotakis
C: 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A critical biomarker of
oxidative stress and carcinogenesis. J Environ Sci Health C,
Environ Carcinog Ecotoxicol Rev. 27:120–139. 2009. View Article : Google Scholar
|
|
37
|
Zhang Q, Karnak D, Tan M, Lawrence TS,
Morgan MA and Sun Y: FBXW7 facilitates nonhomologous end-joining
via K63-linked polyubiquitylation of XRCC4. Mol Cell. 61:419–433.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao Z, Jiang Y, Liu X, Seluanov A and
Gorbunova V: DNA repair by homologous recombination, but not by
nonhomologous end joining, is elevated in breast cancer cells.
Neoplasia. 11:683–691. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shrivastav M, De Haro LP and Nickoloff JA:
Regulation of DNA double-strand break repair pathway choice. Cell
Res. 18:134–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
del Alcazar Gil CR, Hardebeck MC,
Mukherjee B, Tomimatsu N, Gao X, Yan J, Xie XJ, Bachoo R, Li L,
Habib AA and Burma S: Inhibition of DNA double-strand break repair
by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for
radiosensitization of glioblastoma. Clin Cancer Res. 20:1235–1248.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gursoy-Yuzugullu O, Carman C, Serafim RB,
Myronakis M, Valente V and Price BD: Epigenetic therapy with
inhibitors of histone methylation suppresses DNA damage signaling
and increases glioma cell radiosensitivity. Oncotarget.
8:24518–24532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maachani UB, Kramp T, Hanson R, Zhao S,
Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K and
Tandle A: Targeting MPS1 enhances radiosensitization of human
glioblastoma by modulating DNA repair proteins. Mol Cancer Res.
13:852–862. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sarkar A, Sreenivasan Y, Ramesh GT and
Manna SK: beta-D-Glucoside suppresses tumor necrosis factor-induced
activation of nuclear transcription factor kappaB but potentiates
apoptosis. J Biol Chem. 279:33768–33781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rajendran P, Ekambaram G and Sakthisekaran
D: Protective role of mangiferin against Benzo(a)pyrene induced
lung carcinogenesis in experimental animals. Biol Pharm Bull.
31:1053–1058. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kass EM and Jasin M: Collaboration and
competition between DNA double-strand break repair pathways. FEBS
Lett. 584:3703–3708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abraham RT: Checkpoint signalling:
Focusing on 53BP1. Nat Cell Biol. 4:E277–E279. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ward IM, Minn K, van Deursen J and Chen J:
p53 Binding protein 53BP1 is required for DNA damage responses and
tumor suppression in mice. Mol Cell Biol. 23:2556–2563. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kurz EU and Lees-Miller SP: DNA
damage-induced activation of ATM and ATM-dependent signaling
pathways. DNA Repair. 3:889–900. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Riballo E, Kühne M, Rief N, Doherty A,
Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, et al: A
pathway of double-strand break rejoining dependent upon ATM,
Artemis, and proteins locating to gamma-H2AX foci. Mol Cell.
16:715–724. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Traven A and Heierhorst J: SQ/TQ cluster
domains: Concentrated ATM/ATR kinase phosphorylation site regions
in DNA-damage-response proteins. Bioessays. 27:397–407. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fernandez-Capetillo O, Chen HT, Celeste A,
Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero
RD, Motoyama N, et al: DNA damage-induced G2-M
checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol.
4:993–997. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mukherjee B, Tomimatsu N, Amancherla K,
Camacho CV, Pichamoorthy N and Burma S: The dual PI3K/mTOR
inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and
DNA-PKCs-mediated DNA damage responses. Neoplasia. 14:34–43. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lei J, Zhou C, Hu H, Hu L, Zhao M, Yang Y,
Chuai Y, Ni J and Cai J: Mangiferin aglycone attenuates
radiation-induced damage on human intestinal epithelial cells. J
Cell Biochem. 113:2633–2642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo HW, Yun CX, Hou GH, Du J, Huang X, Lu
Y, Keller ET, Zhang J and Deng JG: Mangiferin attenuates TH1/TH2
cytokine imbalance in an ovalbumin-induced asthmatic mouse model.
PLoS One. 9:e1003942014. View Article : Google Scholar : PubMed/NCBI
|
